President Trump says U.S. Rep. Nancy Pelosi, the California lawmaker conservatives love to hate, has earned another turn as speaker of the House. Does that signal the two might be able to work together on major policy issues if she’s elected?

It’s the question everyone in Washington, D.C., is asking after Democrats regained control of the House on Tuesday, placing Pelosi, the House minority leader, in line for the speakership, but the answer may be the most consequential for the pharmaceutical industry.